Further analysis of the inhibition by agmatine on the cardiac sympathetic outflow: Role of the α-adrenoceptor subtypes.

Eur J Pharmacol

Facultad de Ciencias Químico-Biológicas, Universidad Autónoma de Campeche, Av. Universidad s/n, Col. Buenavista, C.P. 24039 Campeche, Campeche, Mexico.

Published: June 2017

This study has investigated the role of the α-adrenoceptor subtypes involved in the inhibition of the cardiac sympathetic outflow induced by intravenous (i.v) infusions of agmatine. Therefore, we analysed the effect of an i.v. bolus injections of the selective antagonists BRL 44408 (300μg/kg; α), imiloxan (3000μg/kg; α), and JP-1302 (300μg/kg; α) given separately, and their combinations: BRL 44408 plus Imiloxan, JP 1302 plus imiloxan, BRL 44408 plus JP-1302, BRL 44408 plus imiloxan plus JP-1302 on the cardiac sympatho-inhibition of agmatine. Also, the effect of the combination BRL 44408 plus JP-1302 plus AGN 192403 (3000μg/kg; I antagonist) was evaluated. In this way, i.v. infusions of 1000μg/kg min of agmatine, but not 300, inhibited the tachycardic response induced by electrical stimulation. Furthermore, the antagonists used or their combinations had no effect on the electrically-induced tachycardic response. On the other hand, the inhibitory response of agmatine was: (1) partially antagonized by BRL 44408 or JP-1302 given separately, a similar response was observed when we administered their combination with imiloxan, but not by imiloxan alone, (2) antagonized in greater magnitude by the combination BRL 44408 plus JP-1302 or the combination BRL 44408 plus imiloxan plus JP-1302, and (3) abolished by the combination BRL 44408 plus JP-1302 plus AGN 192403. Taken together, these results demonstrate that the α- and α-adrenoceptor subtypes and I-imidazoline receptors are involved in the inhibition of the cardiac sympathetic outflow induced by agmatine.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2017.03.009DOI Listing

Publication Analysis

Top Keywords

brl 44408
36
44408 jp-1302
20
combination brl
16
cardiac sympathetic
12
sympathetic outflow
12
α-adrenoceptor subtypes
12
44408 imiloxan
12
brl
9
0
9
role α-adrenoceptor
8

Similar Publications

Article Synopsis
  • * Dexmedetomidine has been shown to help mitigate the negative effects on neural stem cells (NSCs) caused by inflammatory factors from sepsis, improving NSC growth and survival in a dose-dependent manner, but its exact mechanism is still unclear.
  • * In animal studies, dexmedetomidine countered the neuroinflammation and cognitive decline linked to SAE, with its protective effects potentially involving the inhibition of specific receptors related to astrocyte activity.
View Article and Find Full Text PDF
Article Synopsis
  • Long sleep deprivation can harm health and cognition.
  • Dexmedetomidine (DEX) helps improve sleep quality and cognitive function in sleep-deprived mice by increasing certain brain cell numbers.
  • DEX's positive effects are linked to reducing neuroinflammation and enhancing hippocampal neurogenesis through specific signaling pathways, highlighting its potential in treating memory issues from sleep deprivation.
View Article and Find Full Text PDF

The differential contribution of spinal α- and α-adrenoceptors in tonic and acute evoked nociception in the rat.

Front Pharmacol

November 2022

Departamento de Neurobiología Del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, Mexico.

Spinal α-adrenoceptor induces analgesia by neuronal inhibition of primary afferent fibers. This family receptor coupled to G proteins can be subdivided into three functional subtypes: α, α and α-adrenoceptors, and current evidence on spinal analgesia supports the relevance of α and seems to exclude the role of α, but the functional contribution of α-adrenoceptors remains elusive. The present study was designed to pharmacologically dissect the contribution of spinal α-adrenoceptor subtypes modulating tonic or acute peripheral nociception.

View Article and Find Full Text PDF

Alpha-2A but not 2B/C noradrenergic receptors in ventral tegmental area regulate phasic dopamine release in nucleus accumbens core.

Neuropharmacology

December 2022

Jagiellonian University, Institute of Applied Psychology, Department of Neurobiology and Neuropsychology, Łojasiewicza Str. 4, 30-348, Krakow, Poland. Electronic address:

Adrenergic receptors (AR) in the ventral tegmental area (VTA) modulate local neuronal activity and, as a consequence, dopamine (DA) release in the mesolimbic forebrain. Such modulation has functional significance: intra-VTA blockade of α-AR attenuates behavioral responses to salient environmental stimuli in rat models of drug seeking and conditioned fear as well as phasic DA release in the nucleus accumbens (NAc). In contrast, α-AR in the VTA has been suggested to act primarily as autoreceptors, limiting local noradrenergic input.

View Article and Find Full Text PDF

Sex-dependent antiallodynic effect of α adrenergic receptor agonist tizanidine in rats with experimental neuropathic pain.

Eur J Pharmacol

April 2022

Neurobiology of Pain Laboratory, Departamento de Farmacobiología, Cinvestav, South Campus. Mexico City, Mexico. Electronic address:

The purpose of this study was to investigate the mechanism of antiallodynic effect of tizanidine in neuropathic rats. Spinal nerve ligation reduced withdrawal threshold which was interpreted as tactile allodynia. Increasing doses of tizanidine induced a dose-dependent antiallodynic effect in nerve injured rats.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!